Eric Benevich is CCO at NEUROCRINE BIOSCIENCES INC (NBIX). They have made 23 open-market trades across 1 company since 2017, most recently 2026-09-11.
CIK 0001643653
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 23 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NBIX | 67,297 | $9.1M |
Shares reported on the most recent Form 4, priced at the 2026-09-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NBIX | SELL · 10b5-1 | 2026-09-09 | 2026-09-10 | $154.61 | $333K | -10.5% | -10.8% | — |
| NBIX | SELL · 10b5-1 | 2025-11-28 | 2025-12-02 | $151.74 | $1.8M | -0.3% | -8.2% | -13.6% |
| NBIX | SELL · 10b5-1 | 2025-02-13 | 2025-02-14 | $116.73 | $503K | +2.2% | -3.1% | +4.6% |
| NBIX | SELL · 10b5-1 | 2025-02-10 | 2025-02-12 | $118.31 | $232K | -1.2% | -5.6% | -0.4% |
| NBIX | SELL · 10b5-1 | 2025-01-31 | 2025-02-04 | $152.94 | $369K | -24.2% | -25.7% | -27.6% |
| NBIX | SELL · 10b5-1 | 2024-04-15 | 2024-04-17 | $133.36 | $5.3M | +4.2% | +6.8% | +10.7% |
| NBIX | SELL · 10b5-1 | 2024-03-14 | 2024-03-15 | $139.38 | $20.9M | -1.0% | -5.4% | -2.1% |
| NBIX | SELL · 10b5-1 | 2024-02-28 | 2024-02-29 | $134.69 | $20.2M | +4.6% | +7.4% | +2.3% |
| NBIX | SELL · 10b5-1 | 2024-02-13 | 2024-02-15 | $133.01 | $292K | +0.4% | +3.9% | +5.9% |
| NBIX | SELL · 10b5-1 | 2024-02-06 | 2024-02-08 | $138.68 | $627K | -3.0% | +2.9% | +3.2% |
| NBIX | SELL · 10b5-1 | 2024-01-31 | 2024-02-02 | $140.78 | $340K | -6.7% | -5.7% | -1.0% |
| NBIX | SELL · 10b5-1 | 2023-08-21 | 2023-08-23 | $107.40 | $172K | +2.1% | +5.6% | +1.8% |
| NBIX | SELL | 2023-02-06 | 2023-02-08 | $102.70 | $4.0M | -2.5% | -8.5% | -7.2% |
| NBIX | SELL | 2023-01-31 | 2023-02-02 | $109.95 | $265K | -5.8% | -7.8% | -9.8% |
| NBIX | SELL | 2023-01-06 | 2023-01-10 | $125.00 | $50K | -0.1% | -4.0% | -5.2% |
| NBIX | SELL | 2022-11-30 | 2022-12-01 | $125.90 | $12.6M | -5.1% | -4.2% | -19.2% |
| NBIX | SELL | 2022-11-08 | 2022-11-10 | $125.33 | $6.2M | -1.7% | -2.8% | -15.0% |
| NBIX | SELL | 2022-11-02 | 2022-11-04 | $125.02 | $2.3M | -7.7% | +1.6% | -11.5% |
| NBIX | SELL | 2022-10-17 | 2022-10-19 | $110.82 | $1.1M | +4.7% | +9.2% | -1.6% |
| NBIX | SELL | 2022-02-07 | 2022-02-09 | $80.57 | $822K | +10.7% | +12.7% | +3.8% |
| NBIX | SELL | 2021-08-16 | 2021-08-18 | $89.62 | $1.0M | +4.7% | +5.3% | -3.7% |
| NBIX | SELL | 2021-02-05 | 2021-02-09 | $116.38 | $1.2M | -4.3% | -18.5% | -21.3% |
| NBIX | SELL | 2021-01-25 | 2021-01-27 | $120.03 | $1.1M | +6.2% | -1.2% | -11.8% |
| NBIX | SELL | 2020-11-12 | 2020-11-16 | $90.71 | $409K | +3.1% | +6.5% | +21.3% |
| NBIX | SELL | 2020-11-02 | 2020-11-04 | $96.53 | $4.0M | -14.6% | -11.3% | +4.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.